Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Surgery Partners's gross profit for the
three
months ended in Jun. 2026 was €165 Mil. Surgery Partners's gross profit for the trailing twelve months (TTM) ended in Jun. 2026 was €651 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Surgery Partners's gross profit for the
three
months ended in Jun. 2026 was €165 Mil. Surgery Partners's Revenue for the
three
months ended in Jun. 2026 was €737 Mil. Therefore, Surgery Partners's Gross Margin % for the quarter that ended in Jun. 2026 was 22.41%.
Surgery Partners had a gross margin of 22.41% for the quarter that ended in Jun. 2026 => Competition eroding margins
During the past 13 years, the highestGross Margin % of Surgery Partners was 28.31%. The lowest was 20.42%. And the median was 23.14%.
Surgery Partners (FRA:1SP) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Surgery Partners had a gross margin of 22.41% for the quarter that ended in Jun. 2026 => Competition eroding margins
Surgery Partners Gross Profit Related Terms
Surgery Partners Gross Profit Historical Data
* Premium members only.
The historical data trend for Surgery Partners's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:1SP vs SNDA, ASTH, AGL: Gross Profit Comparison
For the Medical Care Facilities subindustry, Surgery Partners's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgery Partners Gross Profit vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's Gross Profit distribution charts can be found below:
* The bar in red indicates where Surgery Partners's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €651 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Surgery Partners (FRA:1SP) has a Gross Profit of €651 Mil as of Jun. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on Surgery Partners and its competitors.
Is Surgery Partners' Gross Profit too high?
Surgery Partners' current Gross Profit is €651 Mil. Overall, Surgery Partners has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Surgery Partners' Gross Profit compare to SNDA and ASTH?
Surgery Partners' Gross Profit of €651 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Healthcare Providers & Services company?
A good Gross Profit depends on the Healthcare Providers & Services industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Surgery Partners and its competitors. Surgery Partners's current Gross Profit is €651 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgery Partners stock overvalued right now?
Based on GuruFocus' analysis, Surgery Partners (FRA:1SP) is currently considered Possible Value Trap. The stock's GF Value™ is €21.02, compared to a current price of €12.10 — trading 42.4% below its estimated fair value. The current Gross Profit is €651 Mil. Surgery Partners' overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Surgery Partners (FRA:1SP), the current Gross Profit is €651 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgery Partners (FRA:1SP) Overvalued in 2026?
Based on GuruFocus' analysis, Surgery Partners stock appears to be undervalued.
The current stock price of €12.10 is trading 42.4% below its estimated GF Value™ of €21.02.
GuruFocus considers Surgery Partners to be Possible Value Trap.
Key valuation signals for FRA:1SP:
Gross Profit: €651 Mil
GF Value™: €21.02 vs. price of €12.10 (42.4% below fair value)
No single metric tells the full story. See the FRA:1SP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
61GF Score
Get the complete analysis for FRA:1SP
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1SP has been successfully added to your 
